InterMune Director Tipped Pal On Drug OK, SEC Tells Jury
By Cara Bayles ( October 24, 2016, 11:06 PM EDT) -- The U.S. Securities and Exchange Commission told a California federal jury Monday that phone records and the timing of trades would prove a former board member at medical company InterMune Inc. had tipped off a friend about the pending approval of the company's lung disease drug before it was public information....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.